Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Resonant Clinical Solutions acquires Creapharm Bioservices

PRIVATESep 03, 20264 days ago

Acquiring Company

Resonant Clinical Solutions

Acquired Company

Creapharm

LeesburgFranceBiotechnologyHealth CareManufacturingBiotechnologyHealth CarePharmaceutical

Description

Resonant Clinical Solutions has acquired Creapharm Bioservices to enhance its Biorepository capabilities in Europe. This acquisition aims to support complex clinical programs, particularly in cell and gene therapies. With this addition, Resonant strengthens its global offerings and ability to manage sensitive biological materials. The partnership addresses the industry's growing demand for specialized storage solutions.

Company Information

Company

Resonant Clinical Solutions

Location

Leesburg, Virginia, United States

About

Resonant Clinical Solutions is a global provider of outsourced clinical trial solutions. With over 850 employees across the US, UK, and Europe, the company offers personalized solutions that advance clinical and commercial operations. They are agile partners to life science enterprises, providing precision and quality in their services.

Don't miss Resonant Clinical Solutions's next move

Get an email the moment Resonant Clinical Solutions makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for Resonant Clinical Solutions's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Creapharm?

Creapharm was acquired by Resonant Clinical Solutions, based in Leesburg. The deal was reported on September 3, 2026. Resonant Clinical Solutions is a global provider of outsourced clinical trial solutions. Resonant Clinical Solutions is privately held and operates in Biotechnology.

When did Resonant Clinical Solutions acquire Creapharm?

Resonant Clinical Solutions's acquisition of Creapharm was reported on September 3, 2026. Resonant Clinical Solutions has acquired Creapharm Bioservices to enhance its Biorepository capabilities in Europe. This acquisition aims to support complex clinical programs, particularly in cell and gene therapies. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Creapharm do?

With decades of experience in global clinical trial supply management, Creapharm supports Pharma and Biotech key players with customized solutions. It is privately held, operating in Manufacturing, and is based in France.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.